Visualize the interaction of PD1/PD-L1 in situ using BOND RX/RXm Fully Automated Research Stainer
Features
  • Automation of the detection of PD1/PD-L1 interaction
  • High efficiency and reproducibility
  • Capacity for 30 slides in one run
  • Fully optimized with primary antibodies and detection kit included
Related Products
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Naveni PD1/PD-L1 BOND RX HRP

Item No. 41651

Technical Information
Applications
ICC and IHC
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    The Naveni® PD1/PD-L1 BOND RX HRP is an in situ proximity ligation assay kit for the detection of the interaction of PD1 and PD-L1 using BOND RX/RXm Fully Automated Research Stainer. The kit has been validated on FFPE human tissue samples.

    The kit is based on the Naveni® in situ proximity ligation technology with an automated workfflow. It uses two Navenibodies linked to proprietary oligo arms. The primary antibodies included in the kit bind to PD1 and PD-L1 proteins, while Navenbodies then bind to their respective primary antibodies. When Navenbodies are in close proximity, a strong and distinct signal is generated, offering a specific and sensitive detection method for the interaction between PD1 and PD-L1. Read more about Naveni technology.

    Included in the kit:
    • Navenibody targeting human PD1 protein based on clone EH33 CST
    • Navenibody targeting human PD-L1 protein based on clone SP142 Abcam RabMAb®
    • Buffers for blocking and dilutions, and all detection reagents for the PD1/PD-L1 interaction signal
    • Reagents sufficient for 30 FFPE tissue slides, including dead volumes

    Not included in the kit:
    • Leica Biosystems for BOND RX/RXm with standard accessories. • Mounting medium

    Find better prognostic biomarkers
    PD1/PD-L1 signaling has with immune checkpoint inhibitors proven to be significant in cancer progression and treatment. Despite the recent success of immune checkpoint inhibitors, many patients do not benefit from these therapies, and predictive biomarkers improving patient stratification are needed. PD-L1 IHC is commonly used as a biomarker, but the correlation between PD-L1 expression levels and PD1/PD-L1 interaction is not alwyas linear.

    Naveni® PPI
    Proteins perform a wide range of functions and are the cloest way to understand biology. Proteins are also key targets in both health and disease. When proteins carry out their function, they interact with other proteins or molecules. To understand biological pathways and mode of action, we need to get a deeper insight into protein functions and how the protein interacts. Detecting the interactions has until now been either complicated, unspecific, or insensitive. The Naveni® in situ proximity ligation technology enables visualization of protein-protein interaction using one primary antibody for each target protein, without the need to disrupt the tissue microenvironment.

    WARNING This product is not for human or veterinary use.